Letermovir Administration to Prevent Cytomegalovirus Reactivation Is the Potential Risk of Chronic Graft-Versus-Host Disease in Patients Who Received Haploidentical Stem-Cell Transplantation With Post-Transplant Cyclophosphamide

The prevention of chronic graft-versus-host disease (cGVHD) is important for recipients of hematopoietic stem-cell transplantation (HSCT). As one of the etiologies, the relationship between early T-cell recovery and subsequent cGVHD development has been the focus of attention. Recently, letermovir (...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Oncol
Autors principals: Terao, Toshiki, Matsuoka, Ken-ichi, Narita, Kentaro, Tsushima, Takafumi, Yuyama, Satoshi, Kuzume, Ayumi, Tabata, Rikako, Miura, Daisuke, Takeuchi, Masami, Matsue, Kosei
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2021
Matèries:
Oncology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8117228/
https://ncbi.nlm.nih.gov/pubmed/33996594
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.666774
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars